Delivery Order SPE2DB24D1205-SPE2DB25FCQRK
Award Date
10/9/24
Potential Completion Date
10/10/24
Potential Value
$32K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract worth $13,655.88 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of 4,564,184,849 units of the pharmaceutical product DUPIXENT 300 MG/2 ML PEN 2ML. This order is part of a larger $999,999,999.00 indefinite delivery contract (IDC) held by Amerisourcebergen Drug Corp as the prime contractor. The IDC enables Amerisourcebergen to deliver a comprehensive range of...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract worth $4,059.09 to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, for the supply of 4563942820 DUPIXENT 300 MG/2 ML PEN 2ML pharmaceutical products. This delivery order is part of a larger indefinite delivery contract (IDC) awarded to AmerisourceBergen Drug Corp by DLA, with a potential value of $999,999,999.00 and a performance period through December 31, 2025. The IDC...
The U.S. Defense Logistics Agency (DLA) awarded a $34,753.33 firm fixed-price delivery order contract to AmerisourceBergen Drug Corp's Corporate Office division. The contract is for the supply of 4,565,266,536 units of the pharmaceutical product DUPIXENT 300 MG/2 ML PEN 2ML. The award has a completion date of July 29, 2024 and is not designated as a set-aside. AmerisourceBergen, a major pharmaceutical distributor, holds multiple Indefinite Delivery Contracts (IDCs) with the DLA and other federal...
The U.S. Defense Logistics Agency (DLA) awarded a $31,119.15 firm-fixed-price delivery order to Amerisourcebergen Drug Corp's Corporate Office Division for the supply of 4564801842 DUPIXENT 300 MG/2 ML PEN 2ML pharmaceutical products. This delivery order falls under Amerisourcebergen's $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which serves as the primary vehicle for the company to provide a comprehensive range of pharmaceutical products and medical...
The U.S. Defense Logistics Agency (DLA) awarded a firm-fixed price delivery order contract worth $38,700.68 to AmerisourceBergen Drug Corporation's Corporate Office Division. The contract is for the supply of DUPIXENT 300 MG/2 ML PEN 2ML, a pharmaceutical product. The contract has an ultimate completion date of August 12, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued up to $999,999,999 and running through December 2025,...
The Defense Logistics Agency (DLA) awarded a $3,304.72 firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to supply DUPIXENT 300 MG/2 ML PEN 2ML pharmaceuticals. This delivery order is part of a larger indefinite delivery contract (IDC) with a potential value of $999,999,999.00 through December 31, 2025, which serves as the primary contract vehicle for Amerisourcebergen to provide a comprehensive range of medications and healthcare...
The Defense Logistics Agency (DLA) has awarded Delivery Order SPE2DB22D2206 to Amerisourcebergen Drug Corporation's Corporate Office Division, a major pharmaceutical distributor. The $7,501.44 firm fixed-price contract is for the supply of DUPIXENT 300 MG/2 ML PEN 2ML, a prescription medication. This Delivery Order is part of Amerisourcebergen's larger $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which provides a wide range of pharmaceutical products and...
The U.S. Defense Logistics Agency (DLA) awarded a $24,410.04 firm-fixed-price delivery order to AmerisourceBergen Drug Corp's Corporate Office Division for the supply of DUPIXENT 300 MG/2 ML PEN 2ML, a pharmaceutical product. This order was placed under AmerisourceBergen's existing $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which serves as the primary vehicle for the company to provide a wide range of pharmaceutical products and medical supplies to DLA...
The Defense Logistics Agency (DLA) awarded Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a $15,033.39 firm fixed price delivery order contract to provide DUPIXENT 300 MG/2 ML PEN 2ML pharmaceutical products. The contract, which has a completion date of March 1, 2024, was issued under an existing $999,999,999.00 indefinite delivery contract (IDC) awarded solely to Amerisourcebergen Drug Corp to deliver pharmaceutical products and medical supplies to DLA Troop Support...
The U.S. Defense Logistics Agency (DLA) awarded a $14,628.42 firm-fixed-price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide 4564604618 DUPIXENT 300 MG/2 ML PEN 2ML pharmaceutical products. This order is part of a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 that Amerisourcebergen holds with DLA Troop Support Medical, which serves as the primary vehicle for the company to deliver a comprehensive range of...